HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

L Zabaglo, O Stoss, J Ruschoff, D Zielinski, J Salter, M Arfi, Ian Bradbury, U Dafni, M Piccart-Gebhart, M Procter, M Dowsett

    Research output: Contribution to journalArticle

    20 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2761-2766
    JournalAnnals of Oncology
    Volume24
    Issue number11
    DOIs
    Publication statusPublished - 2013

    Cite this

    Zabaglo, L., Stoss, O., Ruschoff, J., Zielinski, D., Salter, J., Arfi, M., Bradbury, I., Dafni, U., Piccart-Gebhart, M., Procter, M., & Dowsett, M. (2013). HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab. Annals of Oncology, 24(11), 2761-2766. https://doi.org/10.1093/annonc/mdt275